Market Research Reports- Consulting Analysis Crystal Market Research Vascular Graft Market | Page 2

Endovascular stent grafts segment occupied the largest share of the overall market in 2016, due to factors
such as decrease in the level of physical activity, increase in the consumption of junk food, tobacco and
alcohol. Cardiovascular diseases segmentaccounted for the largest share of the global market in
2016,owing toincrease in the pervasiveness of hypertension and increase in risk factors such as high blood
sugar and other age related disorders. Polyester based grafts segment accounted for the major share of the
overall market in 2016, due to factors such as excessive tensile strength, raw material availability and
durability. Biological materials segment is expected to witness fastest growth during forecast period
owing to high adoption rate among users and increase demand for more biocompatible vascular grafts.
U.S. occupied the largest share of the North America vascular graft market in 2016, due to factors such as
increase in the healthcare expenditure, advancement in healthcare facilities and high prevalence of
cardiovascular disorders. Furthermore, increasing adoption of technological advanced products will drive
the U.S. market during forecast period. Emerging markets such as China and India arepoised to witness
favorable growth during the forecast period due to factors such as rise in geriatric population and
continuous improvement in healthcare infrastructure. Furthermore, government initiatives in India such as
“Make in India” encourages many players to set up manufacturing plants in thecountry, which is set to
stimulate the market growth during forecast period.
Request a sample copy of Vascular Graft Market Research Report at:
http://www.crystalmarketresearch.com/report-sample/HC0634
Product development is the major strategy adopted by the key players to sustain the market competition.
For instance, in December 2016, Medtronic obtained CE Mark for its Endurant II/IIs stent graft system
for treating abdominal aortic aneurysm patients.
Some of the key players in vascular graft market are W.L. Gore & Associates, Inc., Terumo Medical
Corporation, B. Braun Melsungen AG, Vascutek Ltd, Medtronic Plc., ARTEGRAFT, LeMaitre Vascular
Inc., Heart Medical Europe BV, Bard Peripheral Vascular Inc. and Cook Medical Group.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-
enquiry/HC0634
Key Findings of the Research Study:



Endovascular stent grafts segment accounted for three-fourth share of the global market in 2016,
owing to their wide adoption in treating aortic disorders caused due to diabetes and
cardiovascular devices.
Hemodialysis segment is expected to witness high growth during forecast period owing to
increasing prevalence of diabetic people suffering from kidney related disorders.
Cardiovascular diseases segment accounted for one-fourth share of the global market in 2016
owing to rise in incidences of hypertension, aneurysm, and other age-related disorders.